Citations 1
447 Interim results of a phase 1 study of the novel engineered toxin body TAK-169 in patients with relapsed or refractory multiple myeloma
Kumar, Shaji , Mamuye, Admasu, Dabovic, Kristina, Wang, Jingyuan , Anand, Banmeet, Yuet, Amy, Dholaria, Bhagirathbhai , Dholaria, Bhagirathbhai R , Roy, Vivek
Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A475-A475
